Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy
The degree to which novel value elements such as insurance value impact estimated treatment value for rare, severe genetic diseases such as Duchenne muscular dystrophy is unclear.
The Value of Novel Immuno-Oncology Treatments
This study assesses the value of novel immuno-oncology treatments to society.
Spending and Mortality in US Acute Care Hospitals
Across the US, adults with major medical conditions were less likely to die in hospitals with higher spending levels, even after adjusting for patient risk.
Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
Efficiency and Its Measurement: What Practitioners Need to Know
Stakeholders in US healthcare are increasingly seeking to measure and improve efficiency. This article describes an efficiency concept and some practical measurement challenges.
